18:38 IST
NSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare Limited granted 55,690 stock options to eligible employees under its ESOP 2025 scheme.
Rainbow Childrens Medicare Ltd
- Share price
- ₹1,267.00
- Market cap
- ₹12,868 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 45.1×Sector 53.1×
- Promoter holding
- 49.84%+0.00% QoQ
- FII holding
- 16.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Employee Stock Options 6Earnings Call 6Capacity Expansion 5Other Announcement 4Merger & Restructuring 4Management Change 4Financial Results 3Results Update 2Price Movement Clarification 2Business Update 2Board Meeting Outcome 2Annual General Meeting 2Legal & Regulatory 1Dividend 1Board Meeting Date 1Annual Report 1
Time
6 announcements with these filters
17:03 IST
NSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare Limited announced the grant of 2,570 stock options to an employee under its ESOP 2025 scheme.
20:43 IST
NSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Childrens Medicare allotted 7,483 equity shares under its ESOP scheme. Consequently, the paid-up share capital increased to 101,566,639 shares.
19:39 IST
NSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Childrens Medicare allotted 7,483 equity shares under its ESOP scheme. This resulted in a marginal increase in the company's paid-up share capital.
- Value
- ₹0.07 Cr
18:45 IST
BSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare allotted 7,483 equity shares under its Stock Unit Plan 2023. The shares were issued at ₹10 per share.
21:12 IST
BSE
Employee Stock Options
Rainbow Childrens Medicare Employee Stock Options
Rainbow Children's Medicare granted 2,67,550 stock options to employees under its ESOP Scheme 2025. This long-term incentive program aligns employee interests with shareholder value creation.
- Execution
- Vesting after 1 year; maximum exercise period of 10 years